The pharmaceutical landscape is experiencing a development with the arrival of GLP-1 transdermal systems . These exciting formulations offer a promising alternative to delivering glucagon-like peptide-1 https://victorhzzj872310.csublogs.com/48780788/glp-1-patches-a-new-way-to-treat-blood-sugar